Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06079034 · ClinicalTrials.gov registry record
Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 5,058
- Enrollment target
NCT06079034 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 5,058 participants.
The verdict
NCT06079034 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 5,058 participants
- Enrollment target
Study Summary
There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks to leverage the increased use of VA ECMO in this cohort to enrich an evaluation of the differences in rate of intracranial hemorrhage and ischemic stroke between venovenous (VV) and VA ECMO among infants with respiratory failure where clinicians may choose either strategy. This project is a retrospective review of data in the ELSO registry.
Interventions
- PROCEDURE Venovenous ECMO
- PROCEDURE Venoarterial ECMO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,058 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2023-12-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06079034
The ClinicalTrials.gov registry entry for NCT06079034 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,058 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Venovenous ECMO is the first listed.
NCT06079034 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06079034 about?
NCT06079034 is a clinical study titled "Impact of Cannulation Strategy on Neurologic Injury in Infants With Respiratory Failure". There has been increasing use of venoarterial (VA) extracorporeal membrane oxygenation (ECMO) for infants with respiratory failure, up to 92% of neonatal respiratory support in 2021. This study seeks to leverage the increased use of VA ECMO in this cohort to enrich an evaluation of the differences i...
What is the current status of trial NCT06079034?
This trial is currently completed. The enrollment target is 5,058 participants. The study started on 2023-10-18. Estimated completion is 2023-12-12.
What interventions are being tested in trial NCT06079034?
The interventions under investigation include: Venovenous ECMO (PROCEDURE), Venoarterial ECMO (PROCEDURE).
Who is sponsoring clinical trial NCT06079034?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.